Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ROS1 | P08922 | 6/20 | 0.48 |
| ▸ | ALK | Q9UM73 | 6/20 | 0.48 |
| ▸ | EGFR | P00533 | 13/20 | 0.47 |
| ▸ | LRRK2 | Q5S007 | 2/20 | 0.42 |
| ▸ | GSK3A | P49840 | 1/20 | 0.42 |
| ▸ | MAPK15 | Q8TD08 | 1/20 | 0.42 |
| ▸ | CAMKK2 | Q96RR4 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29904656 | 0.85 | ROS1 (0.56) | ROS1ALKEGFRLRRK2GSK3A | |
| SCHEMBL26906513 | 0.85 | ROS1 (0.56) | ROS1ALKEGFRLRRK2GSK3A | |
| SCHEMBL29904652 | 0.85 | ALK (0.51) | ROS1ALKEGFRLRRK2GSK3A | |
| SCHEMBL26906479 | 0.85 | ALK (0.51) | ROS1ALKEGFRLRRK2GSK3A | |
| SCHEMBL29114897 | 0.84 | EGFR (0.50) | ROS1ALKEGFRLRRK2GSK3A | |
| SCHEMBL29904688 | 0.83 | ROS1 (0.56) | ROS1ALKEGFRLRRK2GSK3A | |
| SCHEMBL26906877 | 0.83 | ROS1 (0.56) | ROS1ALKEGFRLRRK2GSK3A | |
| SCHEMBL26906788 | 0.83 | ALK (0.56) | ROS1ALKEGFRLRRK2GSK3A | |
| SCHEMBL29904685 | 0.83 | ALK (0.56) | ROS1ALKEGFRLRRK2GSK3A | |
| SCHEMBL26906735 | 0.82 | ALK (0.58) | ROS1ALKEGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117120424-A | Pyrimidine derivatives having protein kinase inhibitory activity and therapeutic combinations comprising the same | 泰拉佩克斯有限公司 | 2023-11-24 | — | — | CN | disclosed |